Navigation Links
Masimo Reschedules Release of Third Quarter 2012 Financial Results and Associated Conference Call to Thursday, November 1st Due to Hurricane Sandy
Date:10/29/2012

IRVINE, Calif., Oct. 29, 2012 /PRNewswire/ -- Masimo (NASDAQ: MASI) announced today that due to Hurricane Sandy it has rescheduled release of its third quarter 2012 financial results and associated conference call from Tuesday, October 30, 2012, to Thursday, November 1, 2012.

Masimo will release its financial results for the period ended September 29, 2012 after the market closes on November 1, 2012 and conduct a conference call to review the results at 1:30 p.m. PT (4:30 p.m. ET). The call will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Mark P. de Raad, Executive Vice President and Chief Financial Officer.

Masimo made the change to accommodate members of the investor and financial analyst community being impacted by possible sustained disruption from Hurricane Sandy.

A live webcast of the conference call will be available online from the investor relations page of the company's corporate website at www.masimo.com. The dial-in numbers are (888) 520-7182 for domestic callers and +1 (706) 758-3929 for international callers. The reservation code for both dial-in numbers is 38439591. After the live webcast, the call will be available on Masimo's website through December 1, 2012. In addition, a telephonic replay of the call will be available through November 15, 2012. The replay dial-in numbers are (800) 585-8367 for domestic callers and +1 (855) 859-2056 for international callers. Please use reservation code 38439591.

About Masimo
Masimo (NASDAQ: MASI) is the global leader in innovative noninvasive monitoring technologies that significantly improve patient care—helping solve "unsolvable" problems. In 1995, the company debuted Measure-Through Motion and Low Perfusion pulse oximetry, known as Masimo SET®, which virtually eliminated false alarms and increased pulse oximetry's ability to detect life-threatening events. More than 100 independent and objective studies have shown that Masimo SET® outperforms other pulse oximetry technologies, even under the most challenging clinical conditions, including patient motion and low peripheral perfusion. In 2005, Masimo introduced rainbow SET® Pulse CO-Oximetry technology, allowing noninvasive and continuous monitoring of blood constituents that previously required invasive procedures, including total hemoglobin (SpHb®), oxygen content (SpOCTM), carboxyhemoglobin (SpCO®), methemoglobin (SpMet®), and Pleth Variability Index (PVI®), in addition to SpO2, pulse rate, and perfusion index (PI). In 2008, Masimo introduced Patient SafetyNet™, a remote monitoring and wireless clinician notification system designed to help hospitals avoid preventable deaths and injuries associated with failure to rescue events. In 2009, Masimo introduced rainbow® Acoustic MonitoringTM, the first-ever noninvasive and continuous monitoring of acoustic respiration rate (RRa™).  Masimo's rainbow® SET® technology platform offers a breakthrough in patient safety by helping clinicians detect life-threatening conditions and helping guide treatment options. In 2010, Masimo acquired SEDLine®, a pioneer in the development of innovative brain function monitoring technology and devices. And in 2012, Masimo acquired the assets of Spire Semiconductor, LLC, a maker of advanced light emitting diode (LED) and other advanced component-level technologies; and PHASEIN AB, a developer and manufacturer of ultra-compact mainstream and sidestream capnography, multigas analyzers, and handheld capnometry solutions. Masimo SET® and Masimo rainbow® SET® technologies also can be found in over 100 multiparameter patient monitors from over 50 medical device manufacturers around the world. Founded in 1989, Masimo has the mission of "Improving Patient Outcome and Reducing Cost of Care ... by Taking Noninvasive Monitoring to New Sites and Applications®." Additional information about Masimo and its products may be found at www.masimo.com.

Contact:                                                                
Sheree Aronson
(949) 297-7043 
saronson@masimo.com                                                                     

Masimo, SET, Signal Extraction Technology, Improving Patient Outcome and Reducing Cost of Care... by Taking Noninvasive Monitoring to New Sites and Applications, Rainbow, SpHb, SpOC, SpCO, SpMet, PVI, Rainbow Acoustic Monitoring, RRa, Radical-7, Rad-87, Rad-57,Rad-8, Rad-5,Pulse CO-Oximetry, Pulse CO-Oximeter, and SEDLine  are trademarks or registered trademarks of Masimo Corporation.


'/>"/>
SOURCE Masimo
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Essential Medical Dismisses Patent Case against Masimo and Cercacor
2. Masimo Announces New Low-Profile Infant and Neonatal Pulse Oximetry Sensors
3. Novation Inks Supplier Contract Category Agreement for Masimo SET® pulse oximetry and rainbow® SET Pulse CO-Oximetry™
4. Masimo to Present at William Blair & Company 32nd Annual Growth Stock Conference
5. Masimo CEO Joe Kiani Named Ernst & Young Entrepreneur of the Year
6. Masimo Signs Pronto-7™ Distribution Deal with Henry Schein
7. Masimo Deploys Kinaxis RapidResponse for Global Demand and Supply Balancing
8. Masimo to Report Second Quarter 2012 Financial Results after Market Close on August 1
9. Masimo Signs Pulse Oximetry Distribution Deal with MWI Veterinary Supply
10. Masimo Reports Second Quarter 2012 Financial Results
11. Masimo Enters Noninvasive Multigas Monitoring, including Capnography, with Acquisition of PHASEIN
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/22/2017)... 2017 Summary Provides understanding and ... and agreements entered into by the worlds leading healthcare ... Description The Global Non-Small Cell Lung Cancer Partnering ... access to partnering deals and agreements entered into by ... in partnering deals - Top deals by value ...
(Date:2/22/2017)... PUNE, India , February 22, 2017 ... titled, "Automated Radio Synthesis Modules Market: Global Opportunity Analysis and ... market was worth $20 million in 2015 and projected to ... 6.6% from 2016 to 2022. North America ... market revenues and unit volumes, whereas Asia-Pacific ...
(Date:2/22/2017)... February 22, 2017 A research report by ... America and the continuously changing landscape of the legal ... in the North America , a 30% increase ... to $21.6 billion by the year 2021 representing a 26 percent ... the United States and Canada ...
Breaking Medicine Technology:
(Date:2/22/2017)... ... 2017 , ... Forty-five percent of American respondents feel that ... or friends have also commented about their poor hearing. However, only 13 percent ... reason, suggested by 89 percent of American respondents, is that they don’t want ...
(Date:2/22/2017)... ... 22, 2017 , ... Pet obesity in the U.S. continued to steadily increase ... Association for Pet Obesity Prevention (APOP). During the ninth annual survey, APOP also found ... benefits of corn and grains, value of raw and organic diets, and the best ...
(Date:2/22/2017)... ... February 22, 2017 , ... BrightStar Care Charleston , a home ... University of South Carolina (MUSC) Center on Aging’s Senior Expo on Thursday, March ... Aging is a tremendous resource in our community. We are thrilled to participate in ...
(Date:2/22/2017)... ... February 22, 2017 , ... Alto-Shaam is pleased ... Series Multi-Cook Oven offers up to four ovens in one. Control temperature, fan ... for unmatched evenness in cooking. Alto-Shaam has partnered with Appliance Innovation to introduce ...
(Date:2/21/2017)... ... ... Author Michèle Wolff has a passion for using food as medicine . ... it for optimal health. Wanting to share her knowledge to the world, she debuts ... ” (published by Balboa Press AU). , This book inspires readers to discover ...
Breaking Medicine News(10 mins):